Merck & Co., Inc. (MRK)

119.07 +3.61 (+3.13%) USD  |  NYSE  |  Apr 17, 16:00
118.99 -0.08 (-0.07%) After-Hours: 20:00
More

Merck SG&A Expense (Quarterly) : 2.898B for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for MRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Amgen, Inc. 1.952B
Biogen, Inc. 682.50M
Regeneron Pharmaceuticals, Inc. 775.00M
Terns Pharmaceuticals, Inc. 8.699M
Moderna, Inc. 308.00M